CNBX Pharmaceuticals Inc.
CNBX· OTC
CNBXCNBX Pharmaceuticals Inc.
Filed Jul 14, 2014 · 10-Q · 44 days after period end · 0001019687-14-002718
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$55.85K | -$4.71K | -$4.00K | -$104.83K |
| EPS Diluted | -$0.00 | $0.00 | -$0.01 | -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR
ended May 31, 2014 · filed Jul 14, 2014 · 44 d after period end
